1. |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南. 中华结核和呼吸杂志, 2007, 30(1): 8-17.
|
2. |
Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2017. Available at: http://www.goldcopd.org/. Accessed June 5, 2017.
|
3. |
Zhang S, Wang C, Xi B, et al. Association between the tumour necrosis factor-alpha-308G/A polymorphism and chronic obstructive pulmonary disease: an update. Respirology, 2011, 16(1): 107-115.
|
4. |
Lamprecht B, McBurnie MA, Vollmer WM, et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest, 2011, 139(4): 752-763.
|
5. |
Marciniak SJ, Lomas DA. What can naturally occurring mutations tell us about the pathogenesis of COPD?. Thorax, 2009, 64(4): 359-364.
|
6. |
Wei L, Xu D, Qian Y, et al. Comprehensive analysis of gene expression profile in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis, 2015, 10: 1103-1109.
|
7. |
Hobbs BD, Hersh CP. Integrative genomics of chronic obstructive pulmonary disease. Biochem Biophys Res Commun, 2014, 452(2): 276-286.
|
8. |
Lee PN, Fry JS. Systematic review of the evidence relating FEV1 decline to giving up smoking. BMC Med, 2010, 8: 84.
|
9. |
Klimentidis YC, Vazquez AI, de Los Campos G, et al. Heritability of pulmonary function estimated from pedigree and whole-genome markers. Front Genet, 2013, 4: 174.
|
10. |
Henderson J, Harrison C. Management of COPD in general practice. Aust Fam Physician C, 2012, 41(11): 841.
|
11. |
Wouters EF, Reynaert NL, Dentener MA, et al. Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection?. Proc Am Thorac Soc, 2009, 6(8): 638-647.
|
12. |
Ji J, von Scheele I, Bergstrom J, et al. Compartment differences of inflammatory activity in chronic obstructive pulmonary disease. Respir Res, 2014, 15: 104.
|
13. |
Keatings VM, Collins PD, Scott DM, et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med, 1996, 153(2): 530-534.
|
14. |
Takabatake N, Arao T, Sata M, et al. Circulating levels of soluble Fas ligand in cachexic patients with COPD are higher than those in non-cachexic patients with COPD. Intern Med, 2005, 44(11): 1137-1143.
|
15. |
Eurlings IM, Dentener MA, Mercken EM, et al. A comparative study of matrix remodeling in chronic models for COPD; mechanistic insights into the role of TNF-α. Am J Physiol Lung Cell Mol Physiol, 2014, 307(7): L557-L565.
|
16. |
Zhang L, Gu H, Gu Y, et al. Association between TNF-α -308 G/A polymorphism and COPD susceptibility: a meta-analysis update. Int J Chron Obstruct Pulmon Dis, 2016, 11: 1367-1179.
|
17. |
Cui K, Ge XY, Ma HL. Association of the TNF-α +489 G/A polymorphism with chronic obstructive pulmonary disease risk in Asians: meta-analysis. Genet Mol Res, 2015, 14(2): 5210-5220.
|
18. |
Cui K, Ge XY, Ma HL. Association of -238G/A and -863C/A polymorphisms in the TNF-α gene with chronic obstructive pulmonary disease based on a meta-analysis. Genet Mol Res, 2013, 12(4): 4981-4989.
|
19. |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南(2013 年修订版). 中华结核和呼吸杂志, 2013, 36(1): 1-10.
|
20. |
慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组. 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(草案). 中华哮喘杂志电子版, 2013, 7(1): 1-13.
|
21. |
Sakao S, Tatusumi K, Igari H, et al. Association of tumor necrosis factor-alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2001, 163(2): 420-422.
|
22. |
Huang SL, Su CH, Chang SC, et al. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med, 1997, 156(5): 1436-1439.
|
23. |
Ozdogan N, Tutar N, Demir R, et al. Is TNF-α gene polymorphism related to pulmonary functions and prognosis as determined by FEV1, BMI, COPD exacerbation and hospitalization in patients with smoking-related COPD in a Turkish population?. Rev Port Pneumol, 2014, 20(6): 305-310.
|
24. |
Teramoto S, Ishii T, Ishii M, et al. Variation in the tumour necrosis factor-alpha gene is not associated with susceptibility to Asian COPD. Eur Respir J, 2008, 31(3): 682-683.
|
25. |
Gingo MR, Silveira LJ, Miller YE, et al. Tumour necrosis factor gene polymorphisms are associated with COPD. Eur Respir J, 2008, 31(5): 1005-1012.
|
26. |
Chiang CH, Chuang CH, Liu SL, et al. Transforming growth factor-β1 and tumor necrosis factor-α are associated with clinical severity and airflow limitation of COPD in an additive manner. Lung, 2014, 192(1): 95-102.
|
27. |
Küçükaycan M, Van Krugten M, Pennings HJ, et al. Tumor necrosis factor-α +489G/A gene polymorphism is associated with chronic obstructive pulmonary disease. Respir Res, 2002, 3: 29.
|